45 results
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
16 Aug 23
Current report (foreign)
9:25pm
in the Meeting, which is consistent with the goals of the regulators, stakeholders, and others invested in the corporate governance process. Registered
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
16 Aug 23
Current report (foreign)
9:25pm
invested in the corporate governance process. Registered shareholders and duly appointed proxyholders will be able to attend, participate and vote
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
12 Jul 23
Current report (foreign)
12:00am
with the applicable listing and corporate governance rules and regulations of the Nasdaq.
(b) As of the date hereof, the Common Shares are registered pursuant
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
2 Jun 23
Current report (foreign)
4:03pm
Simon G. Best (OBE) Chair, Human Resources & Corporate Governance Committee Timothy S. Wach Director DR. GARY BRIDGER Director Eugene Siklos Director
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
2 May 23
Notice of Annual Meeting of Shareholders
4:19pm
Nominees
Compensation
Statement of Corporate Governance Practices
Board Mandate
Independence
Chair of the Board & Lead Independent Director
Directors … Committee
External Auditors
The HR & Corporate Governance Committee
Standing Committees' Charters
Other Committees
The Science and Technology Committee
6-K
EX-99.2
825 13w06f
2 May 23
Notice of Annual Meeting of Shareholders
4:19pm
6-K
EX-99.1
tryu66w jpm2ti
15 Dec 22
Notice of Special Meeting of Shareholders
4:03pm
6-K
EX-99.1
rap1m7 4y2ybz0bb
1 Sep 22
Liminal BioSciences Announces Listing Transfer to Nasdaq Capital Market
4:37pm
6-K
EX-99.1
cjaglmy7wd571whqzpw
3 May 22
Notice of Annual Meeting of Shareholders
8:32am
6-K
EX-99.1
5fll2
4 May 21
Notice of Annual and Special Meeting of Shareholders
5:05pm
424B3
8q75s8k2
11 Dec 20
Prospectus supplement
12:00am
424B3
rhut4vhy7 w4o
10 Dec 20
Prospectus supplement
9:53pm
POS AM
1dsl zin8ck0een3nyo
2 Dec 20
Prospectus update (post-effective amendment)
12:00am
F-3
t8l6559 qksv86hd
2 Dec 20
Shelf registration (foreign)
12:00am
F-3
b9d30efh5 vs
1 Dec 20
Shelf registration (foreign)
4:48pm
424B3
acfosa4i18n3l646nunr
12 Nov 20
Prospectus supplement
5:21pm
6-K
EX-99.6
a7d0o
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
424B3
91m lbaor1de4ampm2f0
30 Sep 20
Prospectus supplement
5:14pm